Potent hyperglycemic and hyperinsulinemic effects of thyrotropin-releasing hormone microinjected into the rostroventrolateral medulla and abnormal responses in type 2 diabetic rats.
We identified ventrolateral medullary nuclei in which thyrotropin-releasing hormone (TRH) regulates glucose metabolism by modulating autonomic activity. Immunolabeling revealed dense prepro-TRH-containing fibers innervating the rostroventrolateral medulla (RVLM) and nucleus ambiguus (Amb), which contain, respectively, pre-sympathetic motor neurons and vagal motor neurons. In anesthetized Wistar rats, microinjection of the stable TRH analog RX77368 (38-150 pmol) into the RVLM dose-dependently and site-specifically induced hyperglycemia and hyperinsulinemia. At 150 pmol, blood glucose reached a peak of 180+/-18 mg% and insulin increased 4-fold. The strongest hyperglycemic effect was induced when RX77368 was microinjected into C1 area containing adrenalin cells. Spinal cord transection at cervical-7 abolished the hyperglycemia induced by RVLM RX77368, but not the hyperinsulinemic effect. Bilateral vagotomy prevented the rise in insulin, resulting in a prolonged hyperglycemic response. The hyperglycemic and hyperinsulinemic effects of the TRH analog in the RVLM was peptide specific, since angiotensin II or a substance P analog at the same dose had weak or no effects. Microinjection of RX77368 into the Amb stimulated insulin secretion without influencing glucose levels. In conscious type 2 diabetic Goto-Kakizaki (GK) rats, intracisternal injection of RX77368 induced a remarkably amplified hyperglycemic effect with suppressed insulin response compared to Wistar rats. RX77368 microinjected into the RVLM of anesthetized GK rats induced a significantly potentiated hyperglycemic response and an impaired insulin response, compared to Wistar rats. These results indicate that the RVLM is a site at which TRH induces sympathetically-mediated hyperglycemia and vagally-mediated hyperinsulinemia, whereas the Amb is mainly a vagal activating site for TRH. Hyperinsulinemia induced by TRH in the RVLM is not secondary to the hyperglycemic response. The potentiated hyperglycemic and suppressed hyperinsulinemic responses in diabetic GK rats indicate that an unbalanced "sympathetic-over-vagal" activation by TRH in brainstem RVLM contributes to the pathophysiology of impaired glucose homeostasis in type 2 diabetes.
Ao
Y
Y
Department of Medicine, Division of Digestive Diseases and Brain Research Institute, CURE, Digestive Diseases Research Center, University of California, Los Angeles, CA, USA.
Ko
M
M
Chen
A
A
Marvizon
J C
JC
Adelson
D
D
Song
M K
MK
Go
V L W
VL
Liu
Y Y
YY
Yang
H
H
D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D003924:Diabetes Mellitus, Type 2 / Q000378:metabolism* / Q000503:physiopathology; D006943:Hyperglycemia / Q000378:metabolism* / Q000503:physiopathology; D006946:Hyperinsulinism / Q000378:metabolism* / Q000503:physiopathology; D007328:Insulin / Q000097:blood; D008297:Male; D008526:Medulla Oblongata / Q000187:drug effects / Q000378:metabolism*; D008845:Microinjections; D009412:Nerve Fibers / Q000378:metabolism; D009434:Neural Pathways / Q000503:physiopathology; D011498:Protein Precursors / Q000378:metabolism; D011761:Pyrrolidonecarboxylic Acid / Q000031:analogs & derivatives* / Q000378:metabolism / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D013116:Spinal Cord / Q000503:physiopathology; D013973:Thyrotropin-Releasing Hormone / Q000031:analogs & derivatives* / Q000378:metabolism / Q000494:pharmacology; D014630:Vagus Nerve / Q000503:physiopathology
D001786:Blood Glucose; D007328:Insulin; D011498:Protein Precursors; C063596:prepro-thyrotropin-releasing hormone; D013973:Thyrotropin-Releasing Hormone; C027979:L-pyroglutamyl-L-histidyl-3,3-dimethylprolinamide; D011761:Pyrrolidonecarboxylic Acid
Diabetologia. 1994 Sep;37(9):863-70
7806015
Pancreas. 2001 Mar;22(2):164-71
11249071
Pancreas. 2002 Oct;25(3):301-7
12370543
Eur J Pharmacol. 2002 Sep 27;452(1):11-9
12323381
J Comp Neurol. 1995 Nov 20;362(3):320-30
8576442
Am J Physiol. 1999 Nov;277(5):E927-36
10567022
Endocrinology. 2006 Dec;147(12):6004-10
16959836
Histochem Cell Biol. 2005 Feb;123(2):147-56
15742197
Am J Physiol. 1995 Jan;268(1 Pt 2):R272-7
7840331
Neuroendocrinology. 2009;89(4):361-9
19174604
J Comp Neurol. 1993 Mar 15;329(3):337-53
8096227
Endocrinology. 2005 Dec;146(12):5425-32
16179412
Diabetes Metab Res Rev. 2002 Nov-Dec;18(6):473-83
12469361
Diabetes. 2004 Jul;53(7):1714-20
15220195
Biochem Biophys Res Commun. 1994 Apr 29;200(2):958-65
8179633
Diabetologia. 2000 Apr;43(4):393-410
10819232
Am J Physiol. 1988 May;254(5 Pt 1):G639-43
3129948
Am J Physiol. 1981 Jul;241(1):E22-7
7018264
Clin Exp Hypertens. 2001 Jan-Feb;23(1-2):45-55
11270588
Nat Genet. 1996 Jan;12(1):31-7
8528247
Am J Physiol Regul Integr Comp Physiol. 2008 Apr;294(4):R1304-11
18272663
Brain Res. 1996 Apr 9;715(1-2):136-44
8739632
Endocrinology. 1979 Jul;105(1):146-51
446404
Neuroscience. 1994 Aug;61(3):655-63
7969936
Trends Pharmacol Sci. 1996 Apr;17(4):129-35
8984738
Auton Neurosci. 2000 Oct 30;84(1-2):40-9
11109988
Science. 2005 Jan 21;307(5708):375-9
15662002
Am J Physiol. 1997 Aug;273(2 Pt 2):R805-13
9277572
J Comp Neurol. 1991 Sep 8;311(2):271-88
1753019
Metabolism. 2011 Feb;60(2):215-26
20153492
Am J Physiol. 1989 Sep;257(3 Pt 1):G454-62
2506764
Brain Res. 1992 Sep 11;590(1-2):1-5
1422826
Neuroscience. 1990;35(1):105-19
1694281
Nature. 1980 Sep 11;287(5778):149-51
6776408
Circulation. 2003 Dec 23;108(25):3097-101
14676139
J Pharmacol Exp Ther. 1985 Jun;233(3):755-60
2409270
Regul Pept. 1999 Jan 1;79(1):1-7
9930578
Cell Metab. 2006 Jun;3(6):449-61
16753580
Brain Res Bull. 1995;37(5):487-506
7633897
Endocrinology. 2006 Mar;147(3):1365-76
16357041
J Comp Neurol. 2000 Dec 11;428(2):319-36
11064370
Diabetes. 2001 Feb;50 Suppl 1:S160-3
11272181
Tohoku J Exp Med. 1976 May;119(1):85-90
951706
Life Sci. 1987 Feb 16;40(7):649-57
3100898
Am J Anat. 1988 Apr;181(4):359-76
3133939
Am J Physiol Regul Integr Comp Physiol. 2005 Jun;288(6):R1707-15
15731401
Pharmacol Biochem Behav. 1975;3(1 Suppl):139-43
1226393
Gastroenterology. 1988 Dec;95(6):1470-6
3141237
Nat Med. 2006 Jan;12(1):47-9; discussion 49
16397565
Nat Rev Neurosci. 2006 May;7(5):335-46
16760914
Am J Physiol. 1992 Feb;262(2 Pt 1):G216-22
1539656
Neuroscience. 1991;44(1):223-33
1722891
J Comp Neurol. 1998 Dec 14;402(2):181-96
9845242
Brain Res. 1997 Aug 22;766(1-2):29-38
9359584
Acta Physiol Scand. 1999 Feb;165(2):129-34
10090323
Am J Physiol. 1991 May;260(5 Pt 2):R977-84
1674644
Neuroscience. 1995 Nov;69(2):601-18
8552253
Am J Physiol. 1993 Nov;265(5 Pt 1):G880-6
8238517
J Comp Neurol. 1987 Aug 22;262(4):546-62
3667964
Neurosci Lett. 1994 Jun 6;174(1):43-6
7970152
J Comp Neurol. 2001 Mar 26;432(1):20-34
11241375
Am J Physiol Endocrinol Metab. 2002 Sep;283(3):E436-48
12169436
J Auton Nerv Syst. 1983 Feb;7(2):97-110
6348142
Neurosci Lett. 1989 Sep 25;104(1-2):7-12
2510095
Science. 1979 Jun 8;204(4397):1112-4
451558
Neuroendocrinology. 1997 May;65(5):377-84
9158070
J Biol Chem. 1988 Nov 15;263(32):17189-96
3141416
Proc Natl Acad Sci U S A. 2006 Jul 18;103(29):11063-8
16832065
J Appl Physiol (1985). 2002 May;92(5):2153-61
11960969
Brain Res. 1989 Jul 17;492(1-2):261-70
2752300
Science. 1982 Jan 8;215(4529):188-90
6171884